JPRN-UMIN000007473招募中未知
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancer - PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancer
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University0 个研究点目标入组 25 人开始时间: 2012年3月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) bowel movement control is difficult, because of watery diarrhea and chronic diarrhea. (2) administered flucytosine, Phenytoin, Warfarin potassium (3) Pleural effusion or ascitic fluid accumulates (4) with clinically important infection (5) has active carcinoma except carcinoma in situ (6) with gastrointestinal active ulcer (7) sever complication (Heart failure, renal failure, liver failure, Intestinal paralysis, uncontrollable diabetes etc) (8) severe mental disorder (9) severe drug allergy (10) pregnant women or during the nursing, women who like be pregnant and willing to get pregnant, men who want his partner to be pregnant (11) doctor's decision not to be registered to this study
研究者
相似试验
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
招募中
不适用
A Phase II Study of TS-1 + CDDP + Lentinan combination chemotherapy for unresectable or recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000010724Jichi Medical University35
进行中（未招募）
2 期
PIT-2Primary lung cancerMediastinal lymph node metastasis, Squamous cell carcinomaJPRN-jRCTs031180403Suzuki Kenji45
已完成
2 期
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with resectable stage IIIA-N2 non-small cell lung cancerJPRN-UMIN000018138Gunma University Hospital30
招募中
2 期
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancerJPRN-UMIN000012413Advanced Clinical Trial chest surgery Group (ACTG)80